Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

yttrium Y 90 DOTA monoclonal antibody HuAFP31

Known as: Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium Y 90 Tacatuzumab Tetraxetan, Y90 DOTA MOAB HuAFP31 
A radioimmunoconjugate comprised of the humanized monoclonal antibody tacatuzumab, directed against alpha fetoprotein, that is conjugated to the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Paired imaging/therapy with radiolabeled somatostatin receptor (SSTR) antagonists is a novel approach in neuroendocrine tumors… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2019
2019
Purpose: Radiolabeled somatostatin receptor 2 (SSTR2) antagonists have shown higher tumor uptake and tumor-to-organ ratios than… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Review
2016
Review
2016
Intra-arterial radionuclide therapies serve essentially as internal radiation treatment options for both primary and metastatic… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Review
2015
Review
2015
The commercial pipeline of recombinant antibody therapeutics is robust and dynamic. As of early December 2014, a total of 6 such… Expand
Review
2014
Review
2014
The commercial pipeline of monoclonal antibodies is highly dynamic, with a multitude of transitions occurring during the year as… Expand
2013
2013
The biodistribution of the anti-CD37 radioimmunoconjugate 177Lu-tetraxetan-tetulomab (177Lu-DOTA-HH1) was evaluated… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2013
2013
Objective: Hepatic artery perfusion scintigraphy is a routine procedure for patient evaluation before Y-90 radiomicrosphere… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2009
2009
Pancreatic cancer is a silent disease that most commonly presents in an already metastatic form. Current treatment options… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2009
2009
The use of selective internal radiation therapy for treatment of hepatocellular carcinoma and liver metastases using Y-90 labeled… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4